Dietary Supplementation with Inulin Modulates the Gut Microbiota and Improves Insulin Sensitivity in Prediabetes

Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modul...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of endocrinology Vol. 2021; pp. 1 - 8
Main Authors Wang, Xiaojing, Wang, Tong, Zhang, Qian, Xu, Li, Xiao, Xinhua
Format Journal Article
LanguageEnglish
Published Egypt Hindawi 2021
John Wiley & Sons, Inc
Wiley
Subjects
Online AccessGet full text
ISSN1687-8337
1687-8345
DOI10.1155/2021/5579369

Cover

Loading…
Abstract Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism. Methods. We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. Results. The mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m2. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, P=0.03) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, P=0.02) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, P=0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters. Conclusions. Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes.
AbstractList Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism. Methods. We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. Results. The mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m2. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, P=0.03) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, P=0.02) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, P=0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters. Conclusions. Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes.
Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism. We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. The mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m . After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, =0.03) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, =0.02) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, =0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, , , and both at 3 and 6 months, while with a decrease in the relative abundance of . Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters. Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes.
Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism. Methods. We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. Results. The mean age of 49 subjects was 56.6±6.9 years and BMI was 25.07±3.02kg/m[sup.2]. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38±0.50 vs. 2.22±0.62, P=0.03) and 2-hour post-OGTT insulin (4.01±0.77 vs. 3.74±0.76, P=0.02) and improved HOMA-IR (1.05±0.53 vs. 0.85±0.66, P=0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters. Conclusions. Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes.
Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism. Methods. We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. Results. The mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m2. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, P = 0.03 ) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, P = 0.02 ) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, P = 0.03 ). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters. Conclusions. Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes.
Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism.AIMSAccumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism.We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene.METHODSWe performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene.The mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m2. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, P=0.03) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, P=0.02) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, P=0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters.RESULTSThe mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m2. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, P=0.03) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, P=0.02) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, P=0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters.Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes.CONCLUSIONSInulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes.
Audience Academic
Author Xu, Li
Zhang, Qian
Wang, Xiaojing
Xiao, Xinhua
Wang, Tong
AuthorAffiliation 1 Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
3 State Key Laboratory of Membrane Biology and Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China
2 Department of Endocrinology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China
AuthorAffiliation_xml – name: 3 State Key Laboratory of Membrane Biology and Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China
– name: 1 Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– name: 2 Department of Endocrinology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China
Author_xml – sequence: 1
  givenname: Xiaojing
  surname: Wang
  fullname: Wang, Xiaojing
  organization: Department of EndocrinologyNHC Key Laboratory of EndocrinologyPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChinacacms.ac.cn
– sequence: 2
  givenname: Tong
  surname: Wang
  fullname: Wang, Tong
  organization: Department of EndocrinologyNHC Key Laboratory of EndocrinologyPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChinacacms.ac.cn
– sequence: 3
  givenname: Qian
  surname: Zhang
  fullname: Zhang, Qian
  organization: Department of EndocrinologyNHC Key Laboratory of EndocrinologyPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChinacacms.ac.cn
– sequence: 4
  givenname: Li
  surname: Xu
  fullname: Xu, Li
  organization: State Key Laboratory of Membrane Biology and Tsinghua-Peking Center for Life SciencesSchool of Life SciencesTsinghua UniversityBeijingChinatsinghua.edu.cn
– sequence: 5
  givenname: Xinhua
  orcidid: 0000-0001-5441-7766
  surname: Xiao
  fullname: Xiao, Xinhua
  organization: Department of EndocrinologyNHC Key Laboratory of EndocrinologyPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChinacacms.ac.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34257649$$D View this record in MEDLINE/PubMed
BookMark eNqNk91v0zAQwCM0xD7gjWcUCQkhQTc78VdekKYBo9ImkAbPlmM7jafUDrHTaf8917WUdoIK5SGJ_bvf6ey74-zAB2-z7CVGpxhTelagAp9RyquSVU-yI8wEn4iS0IPNd8kPs-MYbxFijCH8LDssSUE5I9VR1n90NqnhPr8Z-76zc-uTSi74_M6lNp_6sXM-vw5m7FSyMU-tzS_HlF87PYTahaRy5U0-nfdDWMD-1MeHiBvro0tu4dJ9Dr_fBmucqi0onmdPG9VF-2L9Psl-fP70_eLL5Orr5fTi_GqiOUZpgkmDUCGU0YKzqm5oU_HGaMWUJhQzWjIs6toiVRS2YaJmtKamRobVpcEYs_Ikm668Jqhb2Q9uDlXKoJx8WAjDTKohOd1ZiQQinGtwMkEI1ZC1sVwRU3ENGw24Pqxc_VjPrdFwSIPqdqS7O961chYWUhQMY0FA8HYtGMLP0cYk5y5q23XK2zBGWVCKKSeMUEBfP0Jvwzh4OKolhTCnFed_qJmCApxvAuTVS6k8ZxUTkLis9lOipAJDDwB1-hcKHmPnTkOzNQ7Wd7T_F7CV4c1WQGtVl9oYunHZaHHXvB_cMr7avpHNVfxubADerwDo0xgH22wQjORybuRybuR6bgAvHuHarQYBSnPdv4LerYJa5426c_tT_AK8ZSOQ
CitedBy_id crossref_primary_10_1016_j_ijbiomac_2024_132735
crossref_primary_10_3390_nu16172935
crossref_primary_10_3390_nu16203447
crossref_primary_10_1111_1440_1681_13727
crossref_primary_10_3389_fmicb_2022_832151
crossref_primary_10_3389_fnut_2023_1108088
crossref_primary_10_3390_nu16030390
crossref_primary_10_1016_j_carbpol_2022_120422
crossref_primary_10_3389_fnut_2024_1520779
crossref_primary_10_20517_mrr_2023_79
crossref_primary_10_1038_s41467_023_43448_z
crossref_primary_10_3390_foods12122367
crossref_primary_10_1017_S0007114524000904
Cites_doi 10.1016/j.nut.2020.110854
10.1038/ismej.2009.112
10.1136/gutjnl-2012-303304
10.1038/nm.4517
10.3389/fendo.2019.00675
10.1053/j.gastro.2009.08.042
10.1038/nature11450
10.1097/cm9.0000000000000308
10.1038/ejcn.2016.156
10.1017/s0007114510003363
10.1079/nrr200479
10.1007/s00284-010-9582-9
10.1007/s00125-007-0791-0
10.1111/1574-6941.12228
10.1210/jc.2008-1348
10.1155/2020/8892176
10.1093/jn/125.6.1401
10.1177/1535370216654227
10.1007/s00125-018-4658-3
10.1038/s41574-019-0156-z
10.1136/gutjnl-2018-317609
10.1186/s12967-019-02159-0
10.1186/s12944-019-1167-4
10.1186/1475-2859-10-s1-s10
10.1136/gutjnl-2019-318424
10.1017/s095442241700018x
10.2337/dc18-s002
10.1186/s12933-021-01265-y
10.1017/s0007114510002874
10.1007/s00125-018-4550-1
10.1016/j.dsx.2018.07.016
10.1136/bmj.i5953
10.1136/gutjnl-2016-313271
ContentType Journal Article
Copyright Copyright © 2021 Xiaojing Wang et al.
COPYRIGHT 2021 John Wiley & Sons, Inc.
Copyright © 2021 Xiaojing Wang et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2021 Xiaojing Wang et al. 2021
Copyright_xml – notice: Copyright © 2021 Xiaojing Wang et al.
– notice: COPYRIGHT 2021 John Wiley & Sons, Inc.
– notice: Copyright © 2021 Xiaojing Wang et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2021 Xiaojing Wang et al. 2021
DBID RHU
RHW
RHX
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1155/2021/5579369
DatabaseName Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
ProQuest Health & Medical Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed


CrossRef


Publicly Available Content Database
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1687-8345
Editor naciu, Anda Mihaela
Editor_xml – sequence: 1
  givenname: Anda Mihaela
  surname: naciu
  fullname: naciu, Anda Mihaela
EndPage 8
ExternalDocumentID oai_doaj_org_article_080477c53668445c8adfe7a4d97c477f
PMC8261184
A696882639
A683581649
34257649
10_1155_2021_5579369
Genre Journal Article
GeographicLocations China
Germany
GeographicLocations_xml – name: China
– name: Germany
GrantInformation_xml – fundername: National Key R&D Program of China
  grantid: 2017YFC1309603; 2018YFC2001100
– fundername: Beijing Municipal Natural Science Foundation
  grantid: 7202163; 7214275
– fundername: National Natural Science Foundation of China
  grantid: 81170736; 81570715; 81870579; 82000746
GroupedDBID ---
188
29J
2WC
4.4
53G
5GY
5VS
7X7
8FI
8FJ
AAFWJ
AAJEY
AAWTL
ABDBF
ABUWG
ACGFO
ADBBV
ADRAZ
AEGXH
AENEX
AFKRA
AFPKN
AINHJ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
DIK
E3Z
EBD
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IEA
IHR
IHW
ITC
KQ8
M48
O5R
O5S
OK1
PIMPY
RHU
RHW
RHX
RNS
RPM
TR2
TUS
UKHRP
~8M
0R~
24P
AAYXX
ACCMX
ACUHS
ALIPV
CITATION
H13
PGMZT
PHGZM
PHGZT
2UF
C1A
CEFSP
CNMHZ
EJD
IL9
NPM
UZ5
PMFND
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c710t-14f0028adc8769bf5f97fdca6ac451653618bbe0a22ef68b65b5db0d6b3d11163
IEDL.DBID M48
ISSN 1687-8337
IngestDate Wed Aug 27 01:25:42 EDT 2025
Thu Aug 21 18:18:10 EDT 2025
Fri Jul 11 07:57:41 EDT 2025
Sat Aug 23 14:26:33 EDT 2025
Tue Jun 17 22:02:58 EDT 2025
Tue Jun 17 22:02:50 EDT 2025
Tue Jun 10 21:02:55 EDT 2025
Tue Jun 10 21:02:04 EDT 2025
Thu May 22 21:27:07 EDT 2025
Thu May 22 21:26:59 EDT 2025
Wed Feb 19 02:25:29 EST 2025
Tue Jul 01 03:54:37 EDT 2025
Thu Apr 24 23:08:21 EDT 2025
Sun Jun 02 18:54:51 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
https://creativecommons.org/licenses/by/4.0
Copyright © 2021 Xiaojing Wang et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c710t-14f0028adc8769bf5f97fdca6ac451653618bbe0a22ef68b65b5db0d6b3d11163
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Academic Editor: Anda Mihaela naciu
ORCID 0000-0001-5441-7766
OpenAccessLink https://doaj.org/article/080477c53668445c8adfe7a4d97c477f
PMID 34257649
PQID 2550175977
PQPubID 4727234
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_080477c53668445c8adfe7a4d97c477f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8261184
proquest_miscellaneous_2551574645
proquest_journals_2550175977
gale_infotracmisc_A696882639
gale_infotracmisc_A683581649
gale_infotracacademiconefile_A696882639
gale_infotracacademiconefile_A683581649
gale_healthsolutions_A696882639
gale_healthsolutions_A683581649
pubmed_primary_34257649
crossref_primary_10_1155_2021_5579369
crossref_citationtrail_10_1155_2021_5579369
hindawi_primary_10_1155_2021_5579369
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-00-00
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – year: 2021
  text: 2021-00-00
PublicationDecade 2020
PublicationPlace Egypt
PublicationPlace_xml – name: Egypt
– name: New York
PublicationTitle International journal of endocrinology
PublicationTitleAlternate Int J Endocrinol
PublicationYear 2021
Publisher Hindawi
John Wiley & Sons, Inc
Wiley
Publisher_xml – name: Hindawi
– name: John Wiley & Sons, Inc
– name: Wiley
References 22
23
24
25
26
L. Weglarz (31) 2003; 8
27
28
29
30
10
32
11
33
12
34
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – ident: 15
  doi: 10.1016/j.nut.2020.110854
– ident: 34
  doi: 10.1038/ismej.2009.112
– ident: 21
  doi: 10.1136/gutjnl-2012-303304
– ident: 8
  doi: 10.1038/nm.4517
– ident: 22
  doi: 10.3389/fendo.2019.00675
– ident: 33
  doi: 10.1053/j.gastro.2009.08.042
– ident: 27
  doi: 10.1038/nature11450
– ident: 29
  doi: 10.1097/cm9.0000000000000308
– ident: 13
  doi: 10.1038/ejcn.2016.156
– ident: 14
  doi: 10.1017/s0007114510003363
– volume: 8
  start-page: 991
  issue: 4
  year: 2003
  ident: 31
  article-title: Desulfovibrio desulfuricans lipopolysaccharides induce endothelial cell IL-6 and IL-8 secretion and E-selectin and VCAM-1 expression
  publication-title: Cellular & Molecular Biology Letters
– ident: 18
  doi: 10.1079/nrr200479
– ident: 24
  doi: 10.1007/s00284-010-9582-9
– ident: 26
  doi: 10.1007/s00125-007-0791-0
– ident: 32
  doi: 10.1111/1574-6941.12228
– ident: 3
  doi: 10.1210/jc.2008-1348
– ident: 4
  doi: 10.1155/2020/8892176
– ident: 11
  doi: 10.1093/jn/125.6.1401
– ident: 2
  doi: 10.1177/1535370216654227
– ident: 5
  doi: 10.1007/s00125-018-4658-3
– ident: 9
  doi: 10.1038/s41574-019-0156-z
– ident: 30
  doi: 10.1136/gutjnl-2018-317609
– ident: 17
  doi: 10.1186/s12967-019-02159-0
– ident: 28
  doi: 10.1186/s12944-019-1167-4
– ident: 12
  doi: 10.1186/1475-2859-10-s1-s10
– ident: 19
  doi: 10.1136/gutjnl-2019-318424
– ident: 25
  doi: 10.1017/s095442241700018x
– ident: 1
  doi: 10.2337/dc18-s002
– ident: 7
  doi: 10.1186/s12933-021-01265-y
– ident: 23
  doi: 10.1017/s0007114510002874
– ident: 10
  doi: 10.1007/s00125-018-4550-1
– ident: 16
  doi: 10.1016/j.dsx.2018.07.016
– ident: 6
  doi: 10.1136/bmj.i5953
– ident: 20
  doi: 10.1136/gutjnl-2016-313271
SSID ssj0066601
Score 2.3158784
Snippet Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been...
Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
hindawi
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Cholesterol
Dextrose
Diabetes
Dietary supplements
Endocrinology
Feces
Glucose
Glucose tolerance tests
Gut microbiota
Hemoglobin
Insulin
Insulin resistance
Intervention
Lipids
Metabolism
Metabolites
Microbiota
Microbiota (Symbiotic organisms)
Physiological aspects
Plasma
Prebiotics
Prediabetic state
Taxonomy
Type 2 diabetes
Variance analysis
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQJCReEDA-AgWMNOABRWvqr-SxfIwNqQgJJu3N8le0SiOdulRo_z13dpItaFNfeGx9deK78_l-1_MdIXvSOO6FD7lhRuW8MjIvfVHmUoEzzkPN5QzvOy--y8Nj_u1EnFxr9YU5Yak8cGLcPng0XCknmJQl58KVxtdBGe4r5WCgRusLZ14PppINBp88Nj4uJGyhkjHVp7wLgWi_2BdCYSe70WEUa_YPlvnuKWLiP8ubPM9_EyivnUgHD8j9zpWk87SEh-ROaB6R3XkDMPr3JX1HY3JnjJrvkvPPy9Ca9SWNXTxTxjiKhGIclh41mI9OFyuPzbzCBQWvkH7dtHSxTHWaWkNN42mKQMD4Ucpgpz8x_T31n6Dw8cc69LHcx-T44MuvT4d512whd-BktHnBa8Rfxjuwj5WtRV2p2juDwhSFBP4XpbVhamazUMvSSmGFt1MvLfNgLyV7QnaaVROeEcqEARTmKm-85WbGS2aqKng-5Y4Jp1RGPvRc166rRI4NMc50RCRCaJSR7mSUkbcD9XmqwHEL3UcU4ECDdbPjF6BNutMmvU2bMvIaxa_TJdRh9-u5LLFQnOTV7RSVBLQCDl9G3kcKtBCwLGe6iw7AHKy1NZprG-XVnJMRJdgAN5roxuGrX-912ryFg5Ne1XVnyS40QE4w2lilMCNvhmF8AGbnNWG1iTSFUPgfeUaepp0xPIhFSIuvqEZ7ZiSn8UizPI11zuHdAf7y5_9DsC_IPVxqCp5NyE673oSX4E629lW0HH8BYYZt4Q
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJCRe0GB8hBUw0oAHFNHUX8lj-RgdUhESTOqb5diOVmmkU5sK7b_nzk4yMjaNx8QXx_b5zvezz3eEHEpjuRPOp4YZlfLCyDR3WZ5KBcY49xWXE7zvPP8mZyf860Is2iBJm3-P8GG1Q3ievRdCYeq5HbIDEwxB-WzRKVwwwEOW40yCvOSMqc6__cq3g5UnBOjv1fDdUwTAv5fXmZlXvSX_Wn6O9sj91m6k08joB-SOrx-S_WkNmPnXBX1Dgydn2CLfJ-eflr4x6wsaUnZG93Acf4qbrvS4RudzOl85zNzlNxRMQPpl29D5MgZlagw1taNxuwHKj6O7Ov2Bvu4x2QSFx-9r323cPiInR59_fpylbWaF1IJF0aQZrxBsGWdBGRZlJapCVc4a5JzIpGAyy8vSj81k4iuZl1KUwpVjJ0vmQDlK9pjs1qvaPyWUCQOQyxbOuJKbCc-ZKQrv-JhbJqxSCXnXjbq2bdhxzH5xpgP8EEIjj3TLo4S87qnPY7iNG-g-IAN7GgySHV7AxNGtzGkwhrlSFnojc86Fhf5WXhnuCmWhoErIS2S_jjdOe1HXU5ljVDjJi5spCgnQBKy7hLwNFKgOoFvWtLcaYHAwsNagrtsoL-scDShB4O2gomuLL78-bGfzLSM46qa6btXWRgO-BA2NIQkT8qovxh-gK17tV9tAkwmFB-IJeRIlo_8RC_gVm6gGMjPg07CkXp6GoObQdsC6_Nn_tf6A3MPHuBc2IrvNeuufg3XYlC-CbvgDnfdbqA
  priority: 102
  providerName: Hindawi Publishing
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdgCIkXBAxYRgEjDXhA0Zr6K3lC5WNsSEVIMKlvkWM7rBIkXZsK7b_nznFSgjb2mPji2D7f5X6X8x0hB1IbboV1sWZaxTzTMk5tksZSgTHOXcnlBM87z77I41P-eS7mweG2DmGVnU70itrWBn3kh2D6wubBbGlvl-cxVo3Cv6uhhMZNcgtTlyH4UvMecIFl7ssfJxIEKWVMdYHvQiDmTw6FUFjPbvBJ8pn7e_18-wyR8e_FZfbnv2GUf32Xju6Ru8GgpNN2B9wnN1z1gOxOKwDTvy7oK-pDPL3vfJcsPyxco1cX1NfybOPGkTEUvbH0pMKodDqrLZb0cmsKtiH9tGnobNFma2o01ZWlrR8C2k_aOHb6DYPg2yoUFC6_rlzn0X1ITo8-fn9_HIeSC7EBU6OJE14iCtPWgJbMilKUmSqt0chSkUjBZJIWhRvrycSVMi2kKIQtxlYWzILWlOwR2anqyu0RyoQGLGYyq23B9YSnTGeZs3zMDRNGqYi86VY9NyEfOZbF-Jl7XCJEjjzKA48i8rKnXrZ5OK6ge4cM7Gkwe7a_Ua9-5EEYc7CSuVIGZiNTzoWB-ZZOaW4zZaChjMhzZH_eHkXtdUA-lSmmi5M8u5oik4BZwOyLyGtPgXoCpmV0OO4Ai4MZtwZ9XUe57XM0oARNYAYdXdq8ffog7OZrVnDUbfU86LN1vpW-iLzom_EFGKNXuXrjaRKh8E95RB63ktG_iHlgi0NUA5kZ8GnYUi3OfLZzGDuAYL7__2E9IXdwEq1zbER2mtXGPQVzsSmeeZ3wBxGaZeM
  priority: 102
  providerName: ProQuest
Title Dietary Supplementation with Inulin Modulates the Gut Microbiota and Improves Insulin Sensitivity in Prediabetes
URI https://dx.doi.org/10.1155/2021/5579369
https://www.ncbi.nlm.nih.gov/pubmed/34257649
https://www.proquest.com/docview/2550175977
https://www.proquest.com/docview/2551574645
https://pubmed.ncbi.nlm.nih.gov/PMC8261184
https://doaj.org/article/080477c53668445c8adfe7a4d97c477f
Volume 2021
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELf2ISReEDA-AqUYacADCjSNP5IHhDrY1iF1mgaV8hY5tsMqjXR0qaD_PXfOx8jUsZdIrS9O7POd73c53xGyK5Rmhhvrq1BJn8VK-JEJIl9IMMaZzZkY4nnnybEYT9nXhCcbpKk2Wk_g5Vpoh_Wkpovz939-rT6BwH90As854vfgA-cSa9Ntkm3YkyQWcZiw9nsC2OiuEHIgQKSiMJRNCPy1uzubk8vh32rqO2eIkX_P1lmi1wMq_9mhDu6Te7VpSUfVWnhANmzxkOyMCoDVP1f0DXXBns6LvkMuvsxsqRYr6qp6VhHkyCKKfll6VGB8Op3MDRb3spcUrER6uCzpZFblbSoVVYWhlUcC2o-qiHb6DcPhq3oUFH6eLGzj231Epgf73z-P_br4gq_B6Cj9gOWIx5TRoC_jLOd5LHOjFTKXB4KHIoiyzA7UcGhzEWWCZ9xkAyOy0ID-FOFjslXMC_uU0JArQGU6NspkTA1ZFKo4toYNmA65ltIj75pZT3WdmRwLZJynDqFwniKP0ppHHnndUl9UGTluoNtDBrY0mEfb_TFf_EhrsUzBXmZSahiNiBjjGsabW6mYiaWGhtwjL5H9aXUotdUG6UhEmDhOsPhmilgAegED0CNvHQWuYRiWVvXBB5gczL3V6es2yqs-ex1K0Am609Ha5qu7d-vVfMsM9pqlnjaCmQIEBSWOWQs98qptxgdgtF5h50tHE3CJ38w98qSSjPZBoYO4-IqyIzMdPnVbitmZy3sO7w5wmD37_9ifk7s4iMpN1iNb5WJpX4DhWGZ9sikT2Sfbe_vHJ6d9536B62ES9J22gOvpOPkLTfRs2g
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEIIXBIyPQGFG2uABRWsSfyQPCBXGaNk6IbFJfQuO7bBKkJZ-aOo_xd_InfNRgjb2tMfWF8f2nc_3u5zvCNkRSjPDjfVVpKTPEiX82ASxLyQY48zmTIR433l4LPqn7POIjzbI7_ouDIZV1jrRKWoz0egj3wPTF4QHs6W9m_7ysWoUfl2tS2iUYnFoV-cA2eZvB_vA390wPPh48qHvV1UFfA2n6cIPWI5AQxkNiiDJcp4nMjda4ah5IHgkgjjLbFeFoc1FnAmecZN1jcgiA4pBRNDvDXITDt4uhhDKUQPwAAm4csuBgI0bR5GsA-05Rx9DsMe5xPp5rSPQVQpozoNbZ4jEz8cX2bv_hm3-dQ4e3CN3KwOW9kqJu082bPGAbPUKAO8_V_QVdSGlzle_Rab7Y7tQsxV1tUPLOHUUBIreXzooMAqeDicGS4jZOQVblH5aLuhwXGaHWiiqCkNLvwe0D8q4efoVg-7LqhcUfn6Z2dqD_JCcXgszHpHNYlLYJ4RGXAH204lRJmMqZHGkksQa1mU64lpKj7ypVz3VVf5zLMPxI3U4iPMUeZRWPPLIbkM9LfN-XEL3HhnY0GC2bvfHZPY9rTZ_ClY5k1LDbETMGNcw39xKxUwiNTTkHtlG9qfl1ddG56Q9EWN6OsGSyykSARgJzEyPvHYUqJdgWlpV1ytgcTDDV6uvqyjXfXZalKB5dKujC5vXT-9U0nzFCnZqUU8r_TlP17vdIy-bZnwBxgQWdrJ0NAGX-GXeI4_LndG8KHJAGocoW3umxad2SzE-c9nVYewAutnT_w9rm9zunwyP0qPB8eEzcgcnVDrmOmRzMVva52CqLrIXTj9Q8u26FdIfoGqjJA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEIgXBIyPQGFG2uABRW0afyQPCBVKWRmdJsGkvmWO7bBKkJZ-aOq_xl_HnfNRgjb2tMfWF8f2nX--u5zvCNkTSjPDjfVVqKTPYiX8yASRLyQo48xmTHTxvvPoSBycsM9jPt4iv6u7MBhWWWGiA2oz1egjb4PqC8KD2dLaWRkWcdwfvJv98rGCFH5prcppFCJyaNfnYL4t3g77wOv9bnfw8duHA7-sMOBrOFmXfsAyNDqU0QAKcZrxLJaZ0QpnwAPBQxFEaWo7qtu1mYhSwVNu0o4RaWgAJEQI_d4gN2UIxybsJTmujT2wClzp5UDAJo7CUFZB95yjvyFocy6xll7jOHRVA-qz4dYZWuXnk4t0339DOP86Ewf3yN1SmaW9Qvruky2bPyA7vRwM-Z9r-oq68FLnt98hs_7ELtV8TV0d0SJmHYWCoieYDnOMiKejqcFyYnZBQS-ln1ZLOpoUmaKWiqrc0MIHAu3DIoaefsUA_KICBoWfx3NbeZMfkpNrYcYjsp1Pc_uE0JArsAN1bJRJmeqyKFRxbA3rMB1yLaVH3lSrnugyFzqW5PiROJuI8wR5lJQ88sh-TT0rcoBcQvceGVjTYOZu98d0_j0pgSABDZ1JqWE2ImKMa5hvZqViJpYaGjKP7CL7k-IabI0_SU9EmKpOsPhyiliAvQQqp0deOwrEKJiWVuVVC1gczPbV6Osqyk2frQYloJBudHRh8-bpvVKar1jBViXqSYmli2Sz8z3ysm7GF2B8YG6nK0cTcIlf6T3yuNgZ9YtCZ1TjEGVjzzT41GzJJ2cu0zqMHQxw9vT_w9oltwGKki_Do8Nn5A7Op_DRtcj2cr6yz0FrXaYvHDxQcnrdePQHjRGnWg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dietary+Supplementation+with+Inulin+Modulates+the+Gut+Microbiota+and+Improves+Insulin+Sensitivity+in+Prediabetes&rft.jtitle=International+journal+of+endocrinology&rft.au=Wang%2C+Xiaojing&rft.au=Wang%2C+Tong&rft.au=Zhang%2C+Qian&rft.au=Xu%2C+Li&rft.date=2021&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1687-8337&rft.volume=2021&rft_id=info:doi/10.1155%2F2021%2F5579369&rft.externalDocID=A683581649
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1687-8337&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1687-8337&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1687-8337&client=summon